Meta-Analysishigh evidence

The Impact of Glucagon-Like Peptide-1 Receptor Agonist Use on Clinical Outcomes After Total Hip and Knee Arthroplasty: A Systematic Review and Meta-Analysis of 346,899 Patients.

The Journal of arthroplasty·June 1, 2026·PMID 41072556

Why it matters

GLP-1RAs are increasingly used for weight loss and diabetes control in arthroplasty patients, but safety concerns about aspiration persist. This analysis provides reassurance on pulmonary safety while highlighting a potential cardiovascular signal that warrants attention in preoperative optimization.

Infographic summary of The Impact of Glucagon-Like Peptide-1 Receptor Agonist Use on Clinical Outcomes After Total Hip and Knee Arthroplasty: A Systematic Review and Meta-Analysis of 346,899 Patients.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled